Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1871 Neoplasms 1257 Colorectal Neoplasms 1057 Carcinoma, Non-Small-Cell Lung 1012 Stomach Neoplasms 802 Carcinoma, Hepatocellular 785 Lung Neoplasms 769 Prostatic Neoplasms 697 Pancreatic Neoplasms 577 Rectal Neoplasms 449 Ovarian Neoplasms 406 Colonic Neoplasms 405 Neoplasm Metastasis 403 Uterine Cervical Neoplasms 400 Recurrence 382 Leukemia, Myeloid, Acute 372 Esophageal Neoplasms 363 Multiple Myeloma 339 Lymphoma 335 Head and Neck Neoplasms 330 Melanoma 312 Precursor Cell Lymphoblastic Leukemia-Lymphoma 292 Brain Neoplasms 264 Urinary Bladder Neoplasms 256 Liver Neoplasms 225 Nasopharyngeal Carcinoma 223 Leukemia 218 Lymphoma, Large B-Cell, Diffuse 216 Polycystic Ovary Syndrome 210 Squamous Cell Carcinoma of Head and Neck 205

Interventions

Morphine 1 Levobupivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Sigmoidal Tumour × Clear all

NCT01825993 2013-04-08

2013/004

Corporacion Parc Tauli

Phase 3 Unknown

Sigmoidal Tumour

Data powered by HemOnc (CC BY 4.0) Colophon ⚡